PsyBio Therapeutics Cash/Share

What is the Cash/Share of PsyBio Therapeutics?

The Cash/Share of PsyBio Therapeutics Corp. is 0.04

What is the definition of Cash/Share?

Cash per share is a company’s cash on hand divided by the company’s shares outstanding.

mrq (most recent quarter)

Cash per share, sometimes called the cash share ratio, is the total cash per share. Cash on hand is reported on the balance sheet. Cash per share is calculated by dividing cash on hand by the total number of shares. Cash per share is the percentage of a firm's share price that is immediately accessible for spending. Cash per share consists of cash and short-term investments. It is money that a firm has on hand and does not come from borrowing or financing activities.

When a firm has a high cash per share, significant percentage of its assets is in a very liquid form. This can indicate economic uncertainty and unwillingness to invest given the current economic climate. High levels of cash per share can indicate that a firm is performing well and is able to reinvest in itself but high cash per share does not always indicate overall financial strength.

Cash/Share of companies in the Health Care sector on TSXV compared to PsyBio Therapeutics

What does PsyBio Therapeutics do?

PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. The company is headquartered in Coconut Creek, Florida.

Companies with cash/share similar to PsyBio Therapeutics